Literature DB >> 33466204

Successful treatment of subdural hemorrhage and retinal hemorrhage in childhood-onset systemic lupus erythematosus associated with thrombocytopenia: Case report.

Yu Wen1, Ping Lu, Huiling Lu, Xiufen Hu.   

Abstract

INTRODUCTION: Thrombocytopenia (TP) is a common complication of childhood-onset systemic lupus erythematosus (SLE), and can range from mild to life-threatening. However, severe TP with multiple hemorrhagic complications is very rare and often predicts a poor prognosis. We describe a 12-year-old Chinese girl who had a history of idiopathic thrombocytopenic purpura who developed SLE that presented as subdural hemorrhage and retinal hemorrhage because of severe TP. PATIENT CONCERNS: A 12-year-old girl was admitted into our hospital because of fever, purpura, and gum bleeding lasting for 12 days. She had a history of idiopathic thrombocytopenic purpura 2 years ago previously. DIAGNOSIS: SLE was diagnosed according to American College of Rheumatology classification criteria. Subdural hemorrhage and retinal hemorrhage were diagnosed based on brain MRI and funduscopy. Severe TP was defined as platelet count <20 × 109/L.
INTERVENTIONS: She was treated first with intravenous immunoglobulin, but it was not efficacious. High-dose methylprednisolone showed short-term efficacy. Then, she was given a glucocorticoid and cyclosporine A plus mycophenolate mofetil. OUTCOMES: Fever, purpura, and gum bleeding were resolved before hospital discharge. Subdural hemorrhage and left hemorrhagic retinopathy were improved remarkably. She had a durable response to refractory TP with no adverse effects during >1-year follow-up.
CONCLUSION: Isolated TP may be an early symptom of childhood-onset SLE . A child with severe TP is prone to develop life-threatening hemorrhagic complications. Glucocorticoids and combined immunosuppressive drugs had a durable response to refractory TP in this patient with no adverse effects.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33466204      PMCID: PMC7808447          DOI: 10.1097/MD.0000000000024231

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  16 in total

Review 1.  Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view.

Authors:  Paola Conigliaro; Massimo Cesareo; Maria Sole Chimenti; Paola Triggianese; Claudia Canofari; Carmen Barbato; Clarissa Giannini; Ada Giorgia Salandri; Carlo Nucci; Roberto Perricone
Journal:  Autoimmun Rev       Date:  2019-01-11       Impact factor: 9.754

2.  Distinct clinical correlates of immune thrombocytopenic purpura at diagnosis of childhood-onset and adult SLE.

Authors:  Gladys Cherres Xavier Esteves; Natali Weniger Spelling Gormezano; Oriany L Pereira; David Kern; Clovis Almeida Silva; Rosa Maria Rodrigues Pereira; Katia Tomie Kozu; Eloisa Bonfá; Nadia Emi Aikawa
Journal:  Mod Rheumatol       Date:  2017-10-25       Impact factor: 3.023

3.  Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.

Authors:  Hyun Kyu Chang
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

4.  Efficacy and safety of tacrolimus in systemic lupus erythematosus patients with refractory thrombocytopenia: a retrospective study.

Authors:  Y Li; X Feng
Journal:  Lupus       Date:  2017-05-31       Impact factor: 2.911

5.  Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus.

Authors:  L Quartuccio; S Sacco; N Franzolini; A Perin; G Ferraccioli; S De Vita
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 6.  The diagnosis and management of the haematologic manifestations of lupus.

Authors:  Alba Velo-García; Sara Guerreiro Castro; David A Isenberg
Journal:  J Autoimmun       Date:  2016-07-25       Impact factor: 7.094

7.  Clinical characteristics and risk factors of intracranial hemorrhage in systemic lupus erythematosus.

Authors:  N Gao; Z L Wang; M T Li; S M Han; Y Q Dang; F C Zhang; T Y Shi; L N Zhang; X F Zeng
Journal:  Lupus       Date:  2013-04       Impact factor: 2.911

Review 8.  Haematological manifestations of lupus.

Authors:  Anum Fayyaz; Ann Igoe; Biji T Kurien; Debashish Danda; Judith A James; Haraldine A Stafford; R Hal Scofield
Journal:  Lupus Sci Med       Date:  2015-03-03

9.  Two cases of refractory thrombocytopenia in systemic lupus erythematosus that responded to intravenous low-dose cyclophosphamide.

Authors:  Hee-Jin Park; Mi-Il Kang; Yoon Kang; Soo-Jin Chung; Sang-Won Lee; Yong-Beom Park; Soo-Kon Lee
Journal:  J Korean Med Sci       Date:  2013-03-04       Impact factor: 2.153

Review 10.  Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Pravesh Kumar Bundhun; Alka Kumari; Feng Huang
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

View more
  1 in total

1.  Pre-Transplant Platelet Refractoriness and Alternative Donors Are Associated With Cytomegalovirus Retinitis in Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia.

Authors:  Yuehong Zhang; Yuqin Liang; Xu Zhang; Shunqing Wang; Jinpeng Cao; Zongyin Gao; Ling Li; Wenjian Mo
Journal:  Front Cell Infect Microbiol       Date:  2022-03-15       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.